A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Clinical trial NCT02177812 · TERMINATED

Trial details

NCT number: NCT02177812
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukaemia, Myelocytic, Acute

Start date: 2014-08-27
Primary completion: 2017-12-08
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.